vs

Side-by-side financial comparison of Allstate (ALL) and Clorox (CLX). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($4.8B vs $922.0M, roughly 5.2× Allstate). On growth, Allstate posted the faster year-over-year revenue change (7.2% vs -6.7%). Over the past eight quarters, Clorox's revenue compounded faster (62.2% CAGR vs -75.8%).

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

ALL vs CLX — Head-to-Head

Bigger by revenue
CLX
CLX
5.2× larger
CLX
$4.8B
$922.0M
ALL
Growing faster (revenue YoY)
ALL
ALL
+13.9% gap
ALL
7.2%
-6.7%
CLX
Faster 2-yr revenue CAGR
CLX
CLX
Annualised
CLX
62.2%
-75.8%
ALL

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
ALL
ALL
CLX
CLX
Revenue
$922.0M
$4.8B
Net Profit
$2.5B
Gross Margin
Operating Margin
-1400.3%
Net Margin
266.6%
Revenue YoY
7.2%
-6.7%
Net Profit YoY
EPS (diluted)
$9.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALL
ALL
CLX
CLX
Q1 26
$922.0M
$4.8B
Q4 25
$17.3B
$1.7B
Q3 25
$17.3B
Q2 25
$16.6B
$2.0B
Q1 25
$16.5B
$1.7B
Q4 24
$16.5B
$1.7B
Q3 24
$16.6B
$1.8B
Q2 24
$15.7B
$1.9B
Net Profit
ALL
ALL
CLX
CLX
Q1 26
$2.5B
Q4 25
$3.8B
$157.0M
Q3 25
$3.7B
Q2 25
$2.1B
$332.0M
Q1 25
$595.0M
$186.0M
Q4 24
$1.9B
$193.0M
Q3 24
$1.2B
$99.0M
Q2 24
$331.0M
$216.0M
Gross Margin
ALL
ALL
CLX
CLX
Q1 26
Q4 25
43.2%
Q3 25
Q2 25
46.5%
Q1 25
44.6%
Q4 24
43.8%
Q3 24
45.8%
Q2 24
46.5%
Operating Margin
ALL
ALL
CLX
CLX
Q1 26
-1400.3%
Q4 25
Q3 25
Q2 25
20.6%
Q1 25
15.2%
Q4 24
14.1%
Q3 24
10.0%
Q2 24
14.5%
Net Margin
ALL
ALL
CLX
CLX
Q1 26
266.6%
Q4 25
22.1%
9.4%
Q3 25
21.7%
Q2 25
12.7%
16.7%
Q1 25
3.6%
11.2%
Q4 24
11.7%
11.4%
Q3 24
7.2%
5.6%
Q2 24
2.1%
11.4%
EPS (diluted)
ALL
ALL
CLX
CLX
Q1 26
$9.25
Q4 25
$14.24
$1.29
Q3 25
$13.95
Q2 25
$7.76
$2.68
Q1 25
$2.11
$1.50
Q4 24
$7.07
$1.54
Q3 24
$4.33
$0.80
Q2 24
$1.13
$1.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALL
ALL
CLX
CLX
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
Stockholders' EquityBook value
$31.6B
Total Assets
$124.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALL
ALL
CLX
CLX
Q1 26
Q4 25
$4.9B
$227.0M
Q3 25
$8.7B
Q2 25
$9.6B
$167.0M
Q1 25
$6.5B
$226.0M
Q4 24
$4.5B
$290.0M
Q3 24
$7.0B
$278.0M
Q2 24
$5.3B
$202.0M
Total Debt
ALL
ALL
CLX
CLX
Q1 26
Q4 25
$7.5B
Q3 25
$8.1B
Q2 25
$8.1B
$2.5B
Q1 25
$8.1B
Q4 24
$8.1B
Q3 24
$8.1B
Q2 24
$8.1B
$2.5B
Stockholders' Equity
ALL
ALL
CLX
CLX
Q1 26
$31.6B
Q4 25
$30.6B
$-125.0M
Q3 25
$27.5B
Q2 25
$24.0B
$321.0M
Q1 25
$22.1B
$27.0M
Q4 24
$21.4B
$-41.0M
Q3 24
$20.9B
$60.0M
Q2 24
$18.6B
$328.0M
Total Assets
ALL
ALL
CLX
CLX
Q1 26
$124.0B
Q4 25
$119.8B
$5.6B
Q3 25
$120.4B
Q2 25
$115.9B
$5.6B
Q1 25
$115.2B
$5.5B
Q4 24
$111.6B
$5.6B
Q3 24
$113.7B
$5.5B
Q2 24
$108.4B
$5.8B
Debt / Equity
ALL
ALL
CLX
CLX
Q1 26
Q4 25
0.24×
Q3 25
0.29×
Q2 25
0.34×
7.74×
Q1 25
0.37×
Q4 24
0.38×
Q3 24
0.39×
Q2 24
0.43×
7.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALL
ALL
CLX
CLX
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$637.0M
FCF MarginFCF / Revenue
13.3%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALL
ALL
CLX
CLX
Q1 26
Q4 25
$3.0B
Q3 25
$3.3B
Q2 25
$1.9B
$294.0M
Q1 25
$2.0B
$286.0M
Q4 24
$1.7B
$180.0M
Q3 24
$3.2B
$221.0M
Q2 24
$2.4B
$340.0M
Free Cash Flow
ALL
ALL
CLX
CLX
Q1 26
$637.0M
Q4 25
$2.9B
Q3 25
$3.2B
Q2 25
$1.9B
$219.0M
Q1 25
$1.9B
$233.0M
Q4 24
$1.7B
$127.0M
Q3 24
$3.1B
$182.0M
Q2 24
$2.3B
$259.0M
FCF Margin
ALL
ALL
CLX
CLX
Q1 26
13.3%
Q4 25
16.7%
Q3 25
18.8%
Q2 25
11.3%
11.0%
Q1 25
11.4%
14.0%
Q4 24
10.0%
7.5%
Q3 24
18.9%
10.3%
Q2 24
14.7%
13.6%
Capex Intensity
ALL
ALL
CLX
CLX
Q1 26
2.5%
Q4 25
0.5%
Q3 25
0.3%
Q2 25
0.0%
3.8%
Q1 25
0.6%
3.2%
Q4 24
0.3%
3.1%
Q3 24
0.4%
2.2%
Q2 24
0.4%
4.3%
Cash Conversion
ALL
ALL
CLX
CLX
Q1 26
Q4 25
0.78×
Q3 25
0.88×
Q2 25
0.89×
0.89×
Q1 25
3.30×
1.54×
Q4 24
0.88×
0.93×
Q3 24
2.69×
2.23×
Q2 24
7.13×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons